Oxidative stress in inherited mitochondrial diseases

Free Radical Biology and Medicine

Volumn 88, Issue , 2015, Pages 10-17

  Hayashi, Genki ^a   Cortopassi, Gino ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Free radicals; Friedreich ataxia; Inflammation; Leber hereditary optic neuropathy; Leigh syndrome; MELAS; MERRF; Mitochondrial disease; Neurodegeneration; Neuroinflammation; Oxidative stress

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ARTICLE; CAENORHABDITIS ELEGANS; CLINICAL EVALUATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ESCHERICHIA COLI; FRIEDREICH ATAXIA; FRUIT FLY MODEL; GENETIC DISORDER; HUMAN; INFLAMMATION; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; MELAS SYNDROME; MERRF SYNDROME; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; PATHOPHYSIOLOGY;

HUMANS; MITOCHONDRIAL DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84942985915     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.05.039     Document Type: Review

References (111)

1. W.J. Koopman, P.H. Willems, and J.A. Smeitink Monogenic mitochondrial disorders N. Engl. J. Med. 366 2012 1132 1141
2. J.R. Small, P.K. Thomas, and A.H. Schapira Dorsal root ganglion proteins in Friedreich's ataxia Neurosci. Lett. 163 1993 3
3. M. Floreani, E. Napoli, A. Martinuzzi, G. Pantano, V. De Riva, R. Trevisan, E. Bisetto, L. Valente, V. Carelli, and F. Dabbeni-Sala Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathy FEBS J. 272 2005 1124 1135
4. S.B. Wu, Y.S. Ma, Y.T. Wu, Y.C. Chen, Y.H. Wei, and D.N.A. Mitochondrial mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome Mol. Neurobiol. 41 2010 256 266
5. Y. Shan, R.A. Schoenfeld, G. Hayashi, E. Napoli, T. Akiyama, M. Iodi Carstens, E.E. Carstens, M.A. Pook, and G.A. Cortopassi Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model Antioxid. Redox Signaling 19 2013 1481 1493
6. A. Barzilai, and K.-I. Yamamoto DNA damage responses to oxidative stress DNA Repair 3 2004 1109 1115
7. E. Garner, and V. Costanzo Studying the DNA damage response using in vitro model systems DNA Repair 8 2009 1025 1037
8. B.S. Berlett, and E.R. Stadtman Protein oxidation in aging, disease, and oxidative stress J. Biol. Chem. 272 1997 20313 20316
9. A. Ayala, M.F. Munoz, and S. Arguelles Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal Oxid. Med. Cell. Longevity 2014 31 2014
10. M.H. Parkinson, J.B. Schulz, and P. Giunti Co-enzyme Q10 and idebenone use in Friedreich's ataxia J. Neurochem. 126 Suppl. 1 2013 125 141
11. V. Campuzano, L. Montermini, D. Molto, L. Pianese, M. Cossee, Cavalcanti, t Francesca, E. Monros, F. Rodius, F. Duclos, A. Monticelli, F. Zara, J. Canizares, H. Koutnikova, S. Bidichandani, C. Gellera, A. Brice, P. Trouillas, G. De Michele, A. Filla, R. De Frutos, F. Palau, P. Patel, S. Di Donato, J. Mandel, S. Cocozza, M. Koenig, and M.,P. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion Science 271 1996 6
12. V. Campuzano, L. Montermini, Y. Lutz, L. Cova, C. Hindelang, S. Jiralerspong, Y. Trottier, S. Kish, B. Faucheux, P. Trouillas, F. Authier, A. Dürr, J. Mandel, A. Vescovi, M. Pandolfo, and M. Koenig Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes Hum. Mol. Genet. 6 1997 10
13. A. Durr, M. Cossee, Y. Agid, V. Campuzano, C. Mignard, C. Penet, J. Mandel, A. Brice, and M. Koenig Clinical and genetic abnormalities in patients with Friedreich's ataxia N. Engl. J. Med. 335 1996 7
14. A. Durr, and A. Brice Clinical and genetic aspects of spinocerebellar degeneration Curr. Opin. Neurol. 13 2000 7
15. M. Ristow, H. Mulder, D. Pomplun, T.J. Schulz, K. Müller-Schmehl, A. Krause, M. Fex, H. Puccio, J. Müller, F. Isken, J. Spranger, D. Müller-Wieland, M.A. Magnuson, M. Möhlig, M. Koenig, and A.F.H. Pfeiffer Frataxin deficiency in pancreatic islets causes diabetes due to loss of β cell mass J. Clin. Invest. 112 2003 527 534
16. C.L. Tsai, and D.P. Barondeau Human frataxin is an allosteric switch that activates the Fe-S cluster biosynthetic complex Biochemistry 49 2010 9132 9139
17. D. Marmolino, M. Manto, F. Acquaviva, P. Vergara, A. Ravella, A. Monticelli, and M. Pandolfo PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia PLoS One 5 2010 e10025
18. V. Calabrese, R. Lodi, C. Tonon, V. D'Agata, M. Sapienza, G. Scapagnini, A. Mangiameli, G. Pennisi, A.M. Stella, and D.A. Butterfield Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia J. Neurol. Sci. 233 2005 145 162
19. R.A. Vaubel, and G. Isaya Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia Mol. Cell. Neurosci. 55 2013 50 61
20. J. Bridwell-Rabb, N.G. Fox, C.L. Tsai, A.M. Winn, and D.P. Barondeau Human frataxin activates Fe-S cluster biosynthesis by facilitating sulfur transfer chemistry Biochemistry 53 2014 4904 4913
21. M. Koenig, and J.L. Mandel Deciphering the cause of Friedreich ataxia Curr. Opin. Neurobiol. 7 1997 689 694
22. A. Wong, J. Yang, P. Cavadini, C. Gellera, B. Lonnerdal, F. Taroni, and G. Cortopassi The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis Hum. Mol. Genet. 8 1999 6
23. G. Tan, L.S. Chen, B. Lonnerdal, C. Gellera, F.A. Taroni, and G.A. Cortopassi Frataxin expression rescues mitochondrial dysfunctions in FRDA cells Hum. Mol. Genet. 10 2001 2099 2107
24. K. Chantrel-Groussard, V. Geromel, H. Puccio, M. Koenig, A. Munnich, A. Rötig, and P. Rustin Disabled early recruitment of antioxidant defense in Friedreich's ataxia Hum. Mol. Genet. 10 2001 8
25. V. Paupe, E. Dassa, S. Goncalves, F. Auchere, M. Lonn, A. Holmgren, and P. Rustin Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia PLoS One 4 2009 11
26. V. D'Oria, S. Petrini, L. Travaglini, C. Priori, E. Piermarini, S. Petrillo, B. Carletti, E. Bertini, and F. Piemonte Frataxin deficiency leads to reduced expression and impaired translocation of NF-E2-related factor (Nrf2) in cultured motor neurons Int. J. Mol. Sci. 14 2013 7853 7865
27. A. Pastore, G. Tozzi, L.M. Gaeta, E. Bertini, V. Serafini, S. Di Cesare, V. Bonetto, F. Casoni, R. Carrozzo, G. Federici, and F. Piemonte Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease J. Biol. Chem. 278 2003 42588 42595
28. M. Sparaco, L.M. Gaeta, F.M. Santorelli, C. Passarelli, G. Tozzi, E. Bertini, A. Simonati, F. Scaravilli, F. Taroni, C. Duyckaerts, M. Feleppa, and F. Piemonte Friedreich's ataxia: oxidative stress and cytoskeletal abnormalities J. Neurol. Sci. 287 2009 111 118
29. G. Tozzi, M. Nuccetelli, M. Lo Bello, S. Bernardini, L. Bellincampi, S. Ballerini, L.M. Gaeta, C. Casali, A. Pastore, G. Federici, E. Bertini, and F. Piemonte Antioxidant enzymes in blood of patients with Friedreich's ataxia Arch. Dis. Child. 86 2002 376 379
30. C.M. Gomes, and R. Santos Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress Oxid. Med. Cell. Longevity 2013 487534 2013
31. A. Bayot, and P. Rustin Friedreich's ataxia, frataxin, PIP5K1B: echo of a distant fracas Oxid. Med. Cell. Longevity 2013 725635 2013
32. C. Lu, and G. Cortopassi Frataxin knockdown causes loss of cytoplasmic iron-sulfur cluster functions, redox alterations and induction of heme transcripts Arch. Biochem. Biophys. 457 2007 111 122
33. G. Hayashi, Y. Shen, T.L. Pedersen, J.W. Newman, M. Pook, and G. Cortopassi Frataxin deficiency increases cyclooxygenase 2 and prostaglandins in cell and animal models of Friedreich's ataxia Hum. Mol. Genet. 23 2014 6838 6847
34. M. Igoillo-Esteve, E. Gurgul-Convey, A. Hu, Romagueira Bichara Dos Santos, L. Abdulkarim, B. Chintawar, S. Marselli, L. Marchetti, P. Jonas, J.C. Eizirik, D.L. Pandolfo, and M. Cnop M. Unveiling a common mechanism of apoptosis in β-cells and neurons in Friedreich's ataxia Hum. Mol. Genet. 24 2015 2274 2286
35. J. Schulz, T. Dehmer, L. Schols, H. Mende, M. Vorgerd, K. Burk, W. Matson, J. Dichgans, M. Beal, and B. MB. Oxidative stress in patients with Friedreich ataxia Neurology 55 2000 3
36. A.C. Haugen, N.A. Di Prospero, J.S. Parker, R.D. Fannin, J. Chou, J.N. Meyer, C. Halweg, J.B. Collins, A. Durr, K. Fischbeck, and B. Van Houten Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology PLoS Genet. 6 2010 e1000812
37. V. Swarup, A.K. Srivastava, M.V. Padma, and M.R. Rajeswari Quantitative profiling and identification of differentially expressed plasma proteins in Friedreich's ataxia J. Neurosci. Res. 91 2013 1483 1491
38. W.M. Johnson, A.L. Wilson-Delfosse, and J.J. Mieyal Dysregulation of glutathione homeostasis in neurodegenerative diseases Nutrients 4 2012 1399 1440
39. J.B. Schulz, J. Lindenau, J. Seyfried, and J. Dichgans Glutathione, oxidative stress and neurodegeneration Eur. J. Biochem. FEBS 267 2000 4904 4911
40. F. Piemonte, A. Pastore, G. Tozzi, D. Tagliacozzi, F. Santorelli, R. Carrozzo, C. Casali, M. Damiano, G. Federici, and E. Bertini Glutathione in blood of patients with Friedreich's ataxia Eur. J. Clin. Invest. 31 2001 5
41. A.L. Bulteau, S. Planamente, L. Jornea, A. Dur, E. Lesuisse, J.M. Camadro, and F. Auchere Changes in mitochondrial glutathione levels and protein thiol oxidation in yfh1 yeast cells and the lymphoblasts of patients with Friedreich's ataxia Biochim. Biophys. Acta 1822 2012 212 225
42. G.M. Enns, T. Moore, A. Le, K. Atkuri, M.K. Shah, K. Cusmano-Ozog, A.K. Niemi, and T.M. Cowan Degree of glutathione deficiency and redox imbalance depend on subtype of mitochondrial disease and clinical status PLoS One 9 2014 e100001
43. A. Campanella, G. Isaya, H.A. O'Neill, P. Santambrogio, A. Cozzi, P. Arosio, and S. Levi The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast Hum. Mol. Genet. 13 2004 2279 2288
44. R.P. Vazquez-Manrique, P. Gonzalez-Cabo, S. Ros, H. Aziz, H.A. Baylis, and F. Palau Reduction of Caenorhabditis elegans frataxin increases sensitivity to oxidative stress, reduces lifespan, and causes lethality in a mitochondrial complex II mutant FASEB J 20 2006 172 174
45. J.V. Llorens, J.A. Navarro, M.J. Martinez-Sebastian, M.K. Baylies, S. Schneuwly, J.A. Botella, and M.D. Molto Causative role of oxidative stress in a Drosophila model of Friedreich ataxia FASEB J 21 2007 333 344
46. S. Lefevre, C. Brossas, F. Auchere, N. Boggetto, J.M. Camadro, and R. Santos Apn1 AP-endonuclease is essential for the repair of oxidatively damaged DNA bases in yeast frataxin-deficient cells Hum. Mol. Genet. 21 2012 4060 4072
47. S. Lefevre, D. Sliwa, P. Rustin, J.M. Camadro, and R. Santos Oxidative stress induces mitochondrial fragmentation in frataxin-deficient cells Biochem. Biophys. Res. Commun. 418 2012 336 341
48. V. Irazusta, E. Obis, A. Moreno-Cermeno, E. Cabiscol, J. Ros, and J. Tamarit Yeast frataxin mutants display decreased superoxide dismutase activity crucial to promote protein oxidative damage Free Radic. Biol. Med. 48 2010 411 420
49. F. Auchere, R. Santos, S. Planamente, E. Lesuisse, and J.M. Camadro Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia Hum. Mol. Genet. 17 2008 2790 2802
50. A.P. Runko, A.J. Griswold, and K.T. Min Overexpression of frataxin in the mitochondria increases resistance to oxidative stress and extends lifespan in Drosophila FEBS Lett. 582 2008 715 719
51. A. Seguin, R. Sutak, A.L. Bulteau, R. Garcia-Serres, J.L. Oddou, S. Lefevre, R. Santos, A. Dancis, J.M. Camadro, J.M. Latour, and E. Lesuisse Evidence that yeast frataxin is not an iron storage protein in vivo Biochim. Biophys. Acta 1802 2010 531 538
52. C.M. Marobbio, I. Pisano, V. Porcelli, F.M. Lasorsa, and L. Palmieri Rapamycin reduces oxidative stress in frataxin-deficient yeast cells Mitochondrion 12 2012 156 161
53. S. Lefevre, D. Sliwa, F. Auchere, C. Brossas, C. Ruckenstuhl, N. Boggetto, E. Lesuisse, F. Madeo, J.M. Camadro, and R. Santos The yeast metacaspase is implicated in oxidative stress response in frataxin-deficient cells FEBS Lett. 586 2012 143 148
54. A. Seguin, A. Bayot, A. Dancis, A. Rogowska-Wrzesinska, F. Auchere, J.M. Camadro, A.L. Bulteau, and E. Lesuisse Overexpression of the yeast frataxin homolog (Yfh1): contrasting effects on iron-sulfur cluster assembly, heme synthesis and resistance to oxidative stress Mitochondrion 9 2009 130 138
55. D.S. Li, K. Ohshima, S. Jiralerspong, M.W. Bojanowski, and M. Pandolfo Knock-out of the cyaY gene in Escherichia coli does not affect cellular iron content and sensitivity to oxidants FEBS Lett. 456 1999 13 16
56. C.J. Miranda, M.M. Santos, K. Ohshima, J. Smith, L. Li, M. Bunting, M. Cosse, M. Koenig, J. Sequeiros, J. Kaplan, and M. Massimo Pandolfo Frataxin knockin mouse FEBS Lett. 512 2002 291 297
57. H. Puccio, D. Simon, M. Cossee, P. Criqui-Filipe, F. Tiziano, J. Melki, C. Hindelang, R. Matyas, P. Rustin, and M. Koenig Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits Nat. Genet. 27 2001 181 186
58. S. Al-Mahdawi, R.M. Pinto, D. Varshney, L. Lawrence, M.B. Lowrie, S. Hughes, Z. Webster, J. Blake, J.M. Cooper, R. King, and M.A. Pook GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology Genomics 88 2006 580 590
59. H. Seznec, D. Simon, C. Bouton, L. Reutenauer, A. Hertzog, P. Golik, V. Procaccio, M. Patel, J.C. Drapier, M. Koenig, and H. Puccio Friedreich ataxia: the oxidative stress paradox Hum. Mol. Genet. 14 2005 463 474
60. M.J. Kim, D.W. Kim, H.J. Jeong, E.J. Sohn, M.J. Shin, E.H. Ahn, S.W. Kwon, Y.N. Kim, D.S. Kim, J. Park, W.S. Eum, H.S. Hwang, and S.Y. Choi Tat-Frataxin protects dopaminergic neuronal cells against MPTP-induced toxicity in a mouse model of Parkinson's disease Biochimie 94 2012 2448 2456
61. R.B. Wilson Therapeutic developments in Friedreich ataxia J. Child Neurol. 27 2012 1212 1216
62. G. Buyse, L. Mertens, G. Di Salvo, I. Matthijs, F. Weidemann, B. Eyskens, W. Goossens, N. Goemans, G.R. Sutherland, and J.L. Van Hove Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring Neurology 60 2003 1679 1681
63. J.M. Cooper, L.V. Korlipara, P.E. Hart, J.L. Bradley, and A.H. Schapira Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy Eur. J. Neurol. 15 2008 1371 1379
64. T.E. Richardson, A.E. Yu, Y. Wen, S.H. Yang, and J.W. Simpkins Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts PLoS One 7 2012 e34600
65. M.G. Cotticelli, A.M. Crabbe, R.B. Wilson, and M.S. Shchepinov Insights into the role of oxidative stress in the pathology of Friedreich ataxia using peroxidation resistant polyunsaturated fatty acids Redox Biol 1 2013 398 404
66. C.N. Kontoghiorghe, A. Kolnagou, and G.J. Kontoghiorghes Antioxidant targeting by deferiprone in diseases related to oxidative damage Front. Biosci. (Landmark 19 2014 862 885 ed.
67. T.E. Richardson, S.H. Yang, Y. Wen, and J.W. Simpkins Estrogen protection in Friedreich's ataxia skin fibroblasts Endocrinology 152 2011 2742 2749
68. P.M. Abruzzo, M. Marini, A. Bolotta, G. Malisardi, S. Manfredini, A. Ghezzo, A. Pini, G. Tasco, and R. Casadio Frataxin mRNA isoforms in FRDA patients and normal subjects: effect of tocotrienol supplementation BioMed Res. Int 2013 276808 2013
69. J. Jones, A. Estirado, C. Redondo, C. Bueno, and S. Martinez Human adipose stem cell-conditioned medium increases survival of Friedreich's ataxia cells submitted to oxidative stress Stem Cells Dev. 21 2012 2817 2826
70. A.A. Sadun, C. La Morgia, and V. Carelli Leber's hereditary optic neuropathy Curr. Treat. Options Neurol 13 2011 109 117
71. D.C. Wallace, G. Singh, M.T. Lott, J.A. Hodge, T.G. Schurr, A.M. Lezza, and L.J. Elsas 2nd; Nikoskelainen, E. K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy Science 242 1988 1427 1430
72. K. Huoponen, J. Vilkki, P. Aula, E.K. Nikoskelainen, and M.L. Savontaus A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy Am. J. Hum. Genet. 48 1991 1147 1153
73. D. Mackey, and N. Howell A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology Am. J. Hum. Genet. 51 1992 1218 1228
74. D.R. Johns, M.J. Neufeld, and R.D. Park An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy Biochem. Biophys. Res. Commun. 187 1992 1551 1557
75. V. Carelli, F.N. Ross-Cisneros, and A.A. Sadun Mitochondrial dysfunction as a cause of optic neuropathies Prog. Retinal Eye Res 23 2004 53 89
76. M.-Y. Yen, S.-H. Kao, A.-G. Wang, and Y.-H. Wei Increased 8-hydroxy-2′-deoxyguanosine in leukocyte DNA in Leber's hereditary optic neuropathy Invest. Ophthalmol. Visual Sci. 45 2004 1688 1691
77. A. Ghelli, A.M. Porcelli, C. Zanna, A. Martinuzzi, V. Carelli, and M. Rugolo Protection against oxidant-induced apoptosis by exogenous glutathione in Leber hereditary optic neuropathy cybrids Invest. Ophthalmol. Visual Sci. 49 2008 671 676
78. C.S. Lin, M.S. Sharpley, W. Fan, K.G. Waymire, A.A. Sadun, V. Carelli, F.N. Ross-Cisneros, P. Baciu, E. Sung, M.J. McManus, B.X. Pan, D.W. Gil, G.R. MacGregor, and D.C. Wallace Mouse mtDNA mutant model of Leber hereditary optic neuropathy Proc. Natl. Acad. Sci. USA 109 2012 20065 20070
79. C. Wang, and R.J. Youle The role of mitochondria in apoptosis Annu. Rev. Genet. 43 2009 95 118
80. C. Battisti, P. Formichi, E. Cardaioli, S. Bianchi, P. Mangiavacchi, S.A. Tripodi, P. Tosi, and A. Federico Cell response to oxidative stress induced apoptosis in patients with Leber's hereditary optic neuropathy J. Neurol. Neurosurg. Psychiatry 75 2004 1731 1736
81. A. Ghelli, C. Zanna, A.M. Porcelli, A.H. Schapira, A. Martinuzzi, V. Carelli, and M. Rugolo Leber's hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium J. Biol. Chem. 278 2003 4145 4150
82. Y. Kobayashi, M.Y. Momoi, K. Tominaga, T. Momoi, K. Nihei, M. Yanagisawa, Y. Kagawa, and S. Ohta A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) Biochem. Biophys. Res. Commun. 173 1990 816 822
83. Y. Goto, I. Nonaka, and S. Horai A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies Nature 348 1990 651 653
84. J.A. Enriquez, A. Chomyn, and G. Attardi MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNALys and premature translation termination Nat. Genet. 10 1995 47 55
85. Y. Goto, S. Horai, T. Matsuoka, Y. Koga, K. Nihei, M. Kobayashi, and I. Nonaka Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation Neurology 42 1992 545 550
86. N. Manwaring, M.M. Jones, J.J. Wang, E. Rochtchina, C. Howard, P. Mitchell, and C.M. Sue Population prevalence of the MELAS A3243G mutation Mitochondrion 7 2007 230 233
87. S.G. Pavlakis, P.C. Phillips, S. DiMauro, D.C. De Vivo, and L.P. Rowland Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome Ann. Neurol. 16 1984 481 488
88. S.F. Berkovic, S. Carpenter, A. Evans, G. Karpati, E.A. Shoubridge, F. Andermann, E. Meyer, J.L. Tyler, M. Diksic, D. Arnold, and et al. Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study Brain 112 1989 1231 1260
89. P.F. Chinnery, M.A. Johnson, T.M. Wardell, R. Singh-Kler, C. Hayes, D.T. Brown, R.W. Taylor, L.A. Bindoff, and D.M. Turnbull The epidemiology of pathogenic mitochondrial DNA mutations Ann. Neurol. 48 2000 188 193
90. Y. Katayama, K. Maeda, T. Iizuka, M. Hayashi, Y. Hashizume, M. Sanada, H. Kawai, and A. Kashiwagi Accumulation of oxidative stress around the stroke-like lesions of MELAS patients Mitochondrion 9 2009 306 313
91. C.Y. Pang, H.C. Lee, and Y.H. Wei Enhanced oxidative damage in human cells harboring A3243G mutation of mitochondrial DNA: implication of oxidative stress in the pathogenesis of mitochondrial diabetes Diabetes Res. Clin. Pract. 54 Suppl. 2 2001 S45 S56
92. N. Ohkoshi, H. Mizusawa, N. Shiraiwa, S. Shoji, K. Harada, and K. Yoshizawa Superoxide dismutases of muscle in mitochondrial encephalomyopathies Muscle Nerve 18 1995 1265 1271
93. M. Filosto, P. Tonin, G. Vattemi, M. Spagnolo, N. Rizzuto, and G. Tomelleri Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases Acta Neuropathol. 103 2002 215 220
94. A.M. James, Y.H. Wei, C.Y. Pang, and M.P. Murphy Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations Biochem. J. 318 1996 401 407
95. H. Rusanen, K. Majamaa, and I.E. Hassinen Increased activities of antioxidant enzymes and decreased ATP concentration in cultured myoblasts with the 3243A→G mutation in mitochondrial DNA Biochim. Biophys. Acta 1500 2000 10 16
96. M. De la Mata, J. Garrido-Maraver, D. Cotan, M.D. Cordero, M. Oropesa-Avila, L.G. Izquierdo, M. De Miguel, J.B. Lorite, E.R. Infante, P. Ybot, S. Jackson, and J.A. Sanchez-Alcazar Recovery of MERRF fibroblasts and cybrids pathophysiology by coenzyme Q10 Neurotherapeutics 9 2012 446 463
97. M. Rikimaru, Y. Ohsawa, A.M. Wolf, K. Nishimaki, H. Ichimiya, N. Kamimura, S. Nishimatsu, S. Ohta, and Y. Sunada Taurine ameliorates impaired mitochondrial function and prevents stroke-like episodes in patients with MELAS Int. Med. (Tokyo) 51 2012 3351 3357
98. D. Cotan, M.D. Cordero, J. Garrido-Maraver, M. Oropesa-Avila, A. Rodriguez-Hernandez, L. Gomez Izquierdo, M. De la Mata, M. De Miguel, J.B. Lorite, E.R. Infante, S. Jackson, P. Navas, and J.A. Sanchez-Alcazar Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts FASEB J 25 2011 2669 2687
99. M. Gerards, R. Kamps, J. van Oevelen, I. Boesten, E. Jongen, B. de Koning, H.R. Scholte, I. de Angst, K. Schoonderwoerd, A. Sefiani, I. Ratbi, W. Coppieters, L. Karim, R. de Coo, B. van den Bosch, and H. Smeets Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome Brain 136 2013 882 890
100. Genetics Home Reference: Leigh syndrome. (http://ghr.nlm.nih.gov/condition/leigh-syndrome); 2011.
101. K. Sofou, I.F. De Coo, P. Isohanni, E. Ostergaard, K. Naess, L. De Meirleir, C. Tzoulis, J. Uusimaa, I.B. De Angst, T. Lonnqvist, H. Pihko, K. Mankinen, L.A. Bindoff, M. Tulinius, and N. Darin A multicenter study on Leigh syndrome: disease course and predictors of survival Orphanet J. Rare Dis. 9 2014 52
102. L.J. Wong Mitochondrial syndromes with leukoencephalopathies Semin. Neurol. 32 2012 55 61
103. S. Rahman, R.B. Blok, H.H. Dahl, D.M. Danks, D.M. Kirby, C.W. Chow, J. Christodoulou, and D.R. Thorburn Leigh syndrome: clinical features and biochemical and DNA abnormalities Ann. Neurol. 39 1996 343 351
104. W.J. Koopman, S. Verkaart, S.E. van Emst-de Vries, S. Grefte, J.A. Smeitink, L.G. Nijtmans, and P.H. Willems Mitigation of NADH: ubiquinone oxidoreductase deficiency by chronic Trolox treatment Biochim. Biophys. Acta 1777 2008 853 859
105. A. Karkucinska-Wieckowska, M. Lebiedzinska, E. Jurkiewicz, M. Pajdowska, J. Trubicka, T. Szymanska-Debinska, J. Suski, P. Pinton, J. Duszynski, M. Pronicki, M.R. Wieckowski, and E. Pronicka Increased reactive oxygen species (ROS) production and low catalase level in fibroblasts of a girl with MEGDEL association (Leigh syndrome, deafness, 3-methylglutaconic aciduria) Folia Neuropathol. 49 2011 56 63
106. A. Quintana, S.E. Kruse, R.P. Kapur, E. Sanz, and R.D. Palmiter Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome Proc. Natl. Acad. Sci. USA 107 2010 10996 11001
107. M.J. Bird, X.W. Wijeyeratne, J.C. Komen, A. Laskowski, M.T. Ryan, D.R. Thorburn, and A.E. Frazier Neuronal and astrocyte dysfunction diverges from embryonic fibroblasts in the Ndufs4fky/fky mouse Biosci. Rep. 34 2014
108. J.D. Mast, K.M. Tomalty, H. Vogel, and T.R. Clandinin Reactive oxygen species act remotely to cause synapse loss in a Drosophila model of developmental mitochondrial encephalopathy Development (Cambridge, England) 135 2008 2669 2679
109. A.W. El-Hattab, L.T. Emrick, S. Chanprasert, W.J. Craigen, and F. Scaglia Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome Int. J. Biochem. Cell Biol. 48 2014 85 91
110. A. Naini, P. Kaufmann, S. Shanske, K. Engelstad, D.C. De Vivo, and E.A. Schon Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox" J. Neurol. Sci. 229-230 2005 187 193
111. J.K. Sandhu, C. Sodja, K. McRae, Y. Li, P. Rippstein, Y.H. Wei, B. Lach, F. Lee, S. Bucurescu, M.E. Harper, and M. Sikorska Effects of nitric oxide donors on cybrids harbouring the mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) A3243G mitochondrial DNA mutation Biochem. J. 391 2005 191 202